242 related articles for article (PubMed ID: 34415849)
1. Antifibrotic drugs in lung transplantation and chronic lung allograft dysfunction: a review.
Bos S; De Sadeleer LJ; Vanstapel A; Beeckmans H; Sacreas A; Yserbyt J; Wuyts WA; Vos R
Eur Respir Rev; 2021 Jun; 30(160):. PubMed ID: 34415849
[TBL] [Abstract][Full Text] [Related]
2. Does continuation of antifibrotics before lung transplantation influence post-transplant outcomes in patients with idiopathic pulmonary fibrosis?
Zhu MZL; Huang JY; Liu DH; Snell GI
Interact Cardiovasc Thorac Surg; 2022 Jan; 34(2):250-254. PubMed ID: 34453531
[TBL] [Abstract][Full Text] [Related]
3. Effect of antifibrotic therapy in patients with idiopathic pulmonary fibrosis undergoing lung transplant in the peri and post-operative period.
Dorey-Stein ZL; Shapiro W; Zhao H; Cordova FC; Criner GJ; Galli JA
Respir Med; 2021 Dec; 190():106599. PubMed ID: 34788735
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of bridging to lung transplantation with antifibrotic drugs in idiopathic pulmonary fibrosis: a case series.
Delanote I; Wuyts WA; Yserbyt J; Verbeken EK; Verleden GM; Vos R
BMC Pulm Med; 2016 Nov; 16(1):156. PubMed ID: 27863518
[TBL] [Abstract][Full Text] [Related]
5. Pirfenidone in restrictive allograft syndrome after lung transplantation: A case series.
Vos R; Wuyts WA; Gheysens O; Goffin KE; Schaevers V; Verleden SE; Van Herck A; Sacreas A; Heigl T; McDonough JE; Yserbyt J; Godinas L; Dupont LJ; Neyrinck AP; Van Raemdonck DE; Verbeken EK; Vanaudenaerde BM; Verleden GM
Am J Transplant; 2018 Dec; 18(12):3045-3059. PubMed ID: 30019840
[TBL] [Abstract][Full Text] [Related]
6. Pirfenidone exerts beneficial effects in patients with IPF undergoing single lung transplantation.
Veit T; Leuschner G; Sisic A; Ceelen F; Munker D; Schmitzer M; Weig T; Michel S; Schneider C; Meiser B; Crispin A; Neurohr C; Behr J; Milger K; Kneidinger N
Am J Transplant; 2019 Aug; 19(8):2358-2365. PubMed ID: 30942945
[TBL] [Abstract][Full Text] [Related]
7. Antifibrotics and lung transplantation: A Spanish multicentre case-controlled study.
Mora Cuesta VM; Iturbe Fernández D; Aguado Ibáñez S; Anguera de Francisco G; Margallo Iribarnegaray J; Carrillo Hernández-Rubio J; Reig Mezquida JP; Pérez Luz V; Laporta Hernández R; de Pablo Gafas A; Solé Jover A; Cifrián Martínez JM
Respirology; 2022 Dec; 27(12):1054-1063. PubMed ID: 36053911
[TBL] [Abstract][Full Text] [Related]
8. Chronic lung allograft dysfunction after lung transplantation: the moving target.
Sato M
Gen Thorac Cardiovasc Surg; 2013 Feb; 61(2):67-78. PubMed ID: 23138970
[TBL] [Abstract][Full Text] [Related]
9. Restrictive allograft dysfunction after lung transplantation: is there a place for nintedanib?-a case report.
Pluchart H; Chanoine S; Briault A; Claustre J; Bedouch P
Fundam Clin Pharmacol; 2020 Jun; 34(3):408-411. PubMed ID: 31755131
[TBL] [Abstract][Full Text] [Related]
10. Acute Rejection and Chronic Lung Allograft Dysfunction: Obstructive and Restrictive Allograft Dysfunction.
Beeckmans H; Bos S; Vos R; Glanville AR
Clin Chest Med; 2023 Mar; 44(1):137-157. PubMed ID: 36774160
[TBL] [Abstract][Full Text] [Related]
11. Real-World Study Analysing Progression and Survival of Patients with Idiopathic Pulmonary Fibrosis with Preserved Lung Function on Antifibrotic Treatment.
Noor S; Nawaz S; Chaudhuri N
Adv Ther; 2021 Jan; 38(1):268-277. PubMed ID: 33098554
[TBL] [Abstract][Full Text] [Related]
12. Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases.
Torrisi SE; Kahn N; Wälscher J; Sarmand N; Polke M; Lars K; Eichinger M; Heussel CP; Palmucci S; Sambataro FM; Sambataro G; Sambataro D; Vancheri C; Kreuter M
BMC Pulm Med; 2019 Nov; 19(1):213. PubMed ID: 31718637
[TBL] [Abstract][Full Text] [Related]
13. Tolerability and efficacy of second-line antifibrotics in patients with idiopathic pulmonary fibrosis.
Cilli A; Uzer F; Sevinç C; Coşkun F; Ursavaş A; Öner Ş; Kose F
Pulm Pharmacol Ther; 2021 Dec; 71():102099. PubMed ID: 34793978
[TBL] [Abstract][Full Text] [Related]
14. Effect of antifibrotic agents on postoperative complications after lung transplantation for idiopathic pulmonary fibrosis.
Moncomble E; Weisenburger G; Picard C; Dégot T; Reynaud-Gaubert M; Nieves A; Mornex JF; Dauriat G; Messika J; Godet C; Hirschi S; Le Pavec J; Borie R; Mordant P; Lortat-Jacob B; Mal H; Bunel V
Respirology; 2024 Jan; 29(1):71-79. PubMed ID: 37789612
[TBL] [Abstract][Full Text] [Related]
15. Therapy options for chronic lung allograft dysfunction-bronchiolitis obliterans syndrome following first-line immunosuppressive strategies: A systematic review.
Benden C; Haughton M; Leonard S; Huber LC
J Heart Lung Transplant; 2017 Sep; 36(9):921-933. PubMed ID: 28662986
[TBL] [Abstract][Full Text] [Related]
16. Switching antifibrotics in patients with idiopathic pulmonary fibrosis: a multi-center retrospective cohort study.
Suzuki Y; Mori K; Aono Y; Kono M; Hasegawa H; Yokomura K; Naoi H; Hozumi H; Karayama M; Furuhashi K; Enomoto N; Fujisawa T; Nakamura Y; Inui N; Nakamura H; Suda T
BMC Pulm Med; 2021 Jul; 21(1):221. PubMed ID: 34247593
[TBL] [Abstract][Full Text] [Related]
17. Chronic Lung Allograft Dysfunction: Evolving Concepts and Therapies.
DerHovanessian A; Wallace WD; Lynch JP; Belperio JA; Weigt SS
Semin Respir Crit Care Med; 2018 Apr; 39(2):155-171. PubMed ID: 29579768
[TBL] [Abstract][Full Text] [Related]
18. Antifibrotic Therapy: Is There a Role in Myositis-Interstitial Lung Disease?
Soskis A; Hallowell R
Respiration; 2021; 100(9):923-932. PubMed ID: 33951665
[TBL] [Abstract][Full Text] [Related]
19. Montelukast in chronic lung allograft dysfunction after lung transplantation.
Vos R; Eynde RV; Ruttens D; Verleden SE; Vanaudenaerde BM; Dupont LJ; Yserbyt J; Verbeken EK; Neyrinck AP; Van Raemdonck DE; Verleden GM;
J Heart Lung Transplant; 2019 May; 38(5):516-527. PubMed ID: 30638839
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcomes and management of lung transplant recipients.
Costa J; Benvenuto LJ; Sonett JR
Best Pract Res Clin Anaesthesiol; 2017 Jun; 31(2):285-297. PubMed ID: 29110800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
